BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24359531)

  • 1. What is personalized medicine: sharpening a vague term based on a systematic literature review.
    Schleidgen S; Klingler C; Bertram T; Rogowski WH; Marckmann G
    BMC Med Ethics; 2013 Dec; 14():55. PubMed ID: 24359531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying systems biology to biomedical research and health care: a précising definition of systems medicine.
    Schleidgen S; Fernau S; Fleischer H; Schickhardt C; Oßa AK; Winkler EC
    BMC Health Serv Res; 2017 Nov; 17(1):761. PubMed ID: 29162092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptual and terminological confusion around personalised medicine: a coping strategy.
    De Grandis G; Halgunset V
    BMC Med Ethics; 2016 Jul; 17(1):43. PubMed ID: 27431285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?
    Fournier V; Prebet T; Dormal A; Brunel M; Cremer R; Schiaratura L
    J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33406631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry based proteomics and metabolomics in personalized oncology.
    Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine in Europe: not yet personal enough?
    Di Paolo A; Sarkozy F; Ryll B; Siebert U
    BMC Health Serv Res; 2017 Apr; 17(1):289. PubMed ID: 28424057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of personalized healthcare and the pivotal role of European regions in its implementation.
    Nardini C; Osmani V; Cormio PG; Frosini A; Turrini M; Lionis C; Neumuth T; Ballensiefen W; Borgonovi E; D'Errico G
    Per Med; 2021 May; 18(3):283-294. PubMed ID: 33825526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare system.
    Schleidgen S; Marckmann G
    BMC Med Ethics; 2013 May; 14():20. PubMed ID: 23705623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department.
    Campanella R; Guarnaccia L; Caroli M; Zarino B; Carrabba G; La Verde N; Gaudino C; Rampini A; Luzzi S; Riboni L; Locatelli M; Navone SE; Marfia G
    J Neurol Sci; 2020 Oct; 417():117083. PubMed ID: 32784071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representing a "revolution": how the popular press has portrayed personalized medicine.
    Marcon AR; Bieber M; Caulfield T
    Genet Med; 2018 Sep; 20(9):950-956. PubMed ID: 29300377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe.
    Horgan D; Jansen M; Leyens L; Lal JA; Sudbrak R; Hackenitz E; Bußhoff U; Ballensiefen W; Brand A
    Public Health Genomics; 2014; 17(5-6):287-98. PubMed ID: 25401385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health 2.0 and Medicine 2.0: tensions and controversies in the field.
    Hughes B; Joshi I; Wareham J
    J Med Internet Res; 2008 Aug; 10(3):e23. PubMed ID: 18682374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in oral personalized medicine: contribution of 'omics'.
    Glurich I; Acharya A; Brilliant MH; Shukla SK
    J Oral Microbiol; 2015; 7():28223. PubMed ID: 26344171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating a common language: defining individualized, personalized and precision prevention in public health.
    Bíró K; Dombrádi V; Jani A; Boruzs K; Gray M
    J Public Health (Oxf); 2018 Dec; 40(4):e552-e559. PubMed ID: 29897560
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.